102
Participants
Start Date
December 30, 2020
Primary Completion Date
May 31, 2022
Study Completion Date
October 14, 2022
Low Dose of KBP-COVID-19
Low Dose of KBP-COVID-19 and adjuvant
High Dose of KBP-COVID-19
High Dose of KBP-COVID-19 and adjuvant
Placebo
Buffered saline solution
PMG Research of Winston-Salem, Winston-Salem
Palm Beach Research Center, West Palm Beach
DM Clinical Research, Tomball
ICON, San Antonio
PanAmerican Clinical Research, Brownsville
Velocity Clinical Research, Meridian
LMC Manna Research, Burlington
LMC Manna Research, Montreal
Lead Sponsor
KBio Inc
INDUSTRY